Effect of different doses of olmesartan medoxomil compared to losartan on proteinuria, renal function and inflammatory markers in type 2 diabetics with nephropathy
Phase of Trial: Phase III
Latest Information Update: 14 Feb 2008
At a glance
- Drugs Losartan; Olmesartan medoxomil
- Indications Diabetic nephropathies; Hypertension
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Inc
- 14 Feb 2008 The expected completion date for this trial is now 1 Sep 2004.
- 03 Nov 2006 New trial record.